Stock Updates

How has Incyte Corporation:(NASDAQ:INCY) performed recently?

Incyte Corporation (NASDAQ: INCY) is a large market cap stock with a market cap of 15407.85. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 241.59, a forward P/E of 60.09 and EPS of 0.34. At a stock price of 86.14 (5.18%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 16.40%, more recently this last year it has grown by 112.10%. The next year growth is going to be about 640.76% and more long-term 55.39% after five years. EPS growth quarter over quarter is 257.80%. Sales growth for the past five years have been 34.70% and sales growth quarter over quarter is 51.10%.

For performance, Incyte Corporation the past week has seen a gain of 5.19%. For the last month performance for Incyte Corporation is -5.24%. While the last quarter is 0.78% and half year, 10.20%. Finally for the year, performance is -15.89%.

The 52-week high for Incyte Corporation, is at -35.53%, and for the 52-week low it comes to a value of 56.62%. The 20-day simple moving average is 4.06% and 2.29% for the 200-day simple moving average.

Volatility for the week is at 3.50%, and for the month it is 3.37%. Incyte Corporation, has a target price of 98.71.

In terms of debt, long term debt/equity is 2.14, and for total debt/equity Incyte Corporation has 0. The gross margin is 96.20%, while operating margin is 15.50%, the profit margin is 7.90%. The current ratio is 4 and the quick ratio is 4.

Insider ownership is at 0.50%, with instituitional ownership at 97.20%. Incyte Corporation has a payout ratio of 0.00%. With the total shares outstanding coming to 188.13. The shares float is 186.94, with the float short at 2.59%, with short ratio coming to 4.47.

In terms of returns, the return on assets see Incyte Corporation, get 6.60%, with its returns on investment at 6.30%. Return on equity is 37.80%. So will the investors see the target price of 98.71, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment